2004GPAC慢性乙型肝炎的臨床管理
《2004GPAC慢性乙型肝炎的臨床管理》內容預覽
Treatment should be given by a physician with expertise in hepatitis.
Notes: As ALT, serology and nucleic acid tests are imperfect markers, a liver biopsy is strongly indicated before treatment is initiated.
Treatment with interferon for 16 weeks will lead to an antiviral response in 25 to 30 per cent of individuals. Treatment with lamivudine for a year or more will lead to an antiviral response in 15 to 40 per cent of individuals. Prolonged therapy increases the risk of antiviral resistance.
What constitutes a hepatitis B antiviral response is complicated because of viral variability in patients and variability in the interpretation of the different available tests, e.g. ALT, HBsAg, HBeAg, HBV DNA. Treatment protocols for chronic hepatitis B are constantly evolving. A recent document on the management of viral hepatitis is available at:http://www.hepatology.ca/cm/FileLib/ViralHepatitisCanadianConsensus2004.pdf
點擊下載完整版：《2004GPAC慢性乙型肝炎的臨床管理》
本站所注明來源為"愛愛醫"的文章，版權歸作者與本站共同所有，非經授權不得轉載。
本站所有轉載文章系出于傳遞更多信息之目的，且明確注明來源和作者，不希望被轉載的媒體或個人可與我們
聯系zlzs@120.net，我們將立即進行刪除處理
熱點圖文
-
參與應激后高代謝反應的主要因素是什么?
研究表明,機體在創傷、感染等應激后出現的以分解代謝占優勢的高代謝狀態的主要...[詳細]
-
創傷、感染后的生理與代謝改變主要有哪些?
機體在遭受感染、創傷、大出血、大手術等打擊后將發生以高代謝狀態為特征的應激...[詳細]
